Gastric Cancer
Gastric cancer, also known as stomach cancer, is a type of cancer that begins in the stomach lining. It can manifest as various forms, including adenocarcinoma, and may spread to other parts of the body.
We are studying a new treatment combination for adults with advanced gastric cancer to see if it works better than standard therapies. This trial is for patients with specific tumor markers.
Health conditions and diseases that the clinical trial is designed to study and treat.
Gastric cancer, also known as stomach cancer, is a type of cancer that begins in the stomach lining. It can manifest as various forms, including adenocarcinoma, and may spread to other parts of the body.
Metastatic gastric cancer refers to stomach cancer that has spread beyond the stomach to other organs, making it more challenging to treat. Symptoms may include severe abdominal discomfort and significant weight loss.
Gastroesophageal junction adenocarcinoma is a type of cancer that occurs at the junction of the esophagus and stomach. It can lead to symptoms such as difficulty swallowing and significant weight loss.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.